Current Available Options in Bariatric Surgery and Their Clinical Outcomes

Cheulsu Byun; Sang-Uk Han

doi:10.4093/jkd.2013.14.2.67

Journal List > J Korean Diabetes > v.14(2) > 1054904

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Byun and Han: Current Available Options in Bariatric Surgery and Their Clinical Outcomes

Focused Issue

J Korean Diabetes 2013;14(2):67-70.

Published online: 7 January 2013

DOI: https://doi.org/10.4093/jkd.2013.14.2.67

Current Available Options in Bariatric Surgery and Their Clinical Outcomes

Cheulsu Byun, Sang-Uk Han

Department of Surgery, School of Medicine, Ajou University, Suwon, Korea

교신저자: 한상욱, 경기도 수원시 영동구 월드컵로 164 (원천동 산5) 아주대학교병원 외과, E-mail: hansu@ajou.ac.kr

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Patients that are morbidly obese require various treatments to reduce the potential health risks associated with obesity-related chronic diseases. Compared to medical management, bariatric surgery can effectively reduce body weight and treat obesity-associated metabolic diseases. Although there are some endoscopic bariatric procedures, the most commonly performed bariatric surgeries are Roux-en-Y gastric bypass (RYGB), adjustable gastric banding (AGB), sleeve gastrectomy (SG) and biliopancreatic diversion (BPD). These types of bariatric surgery can be performed laproscopically with low rates of complications, and generally result in comparable weight loss to medication and lifestyle modification and remission of type 2 diabetes mellitus. Thus, in this study, we describe the current options for bariatric surgery and offer a synopsis of the data on post-operative outcomes.

Keywords: Bariatric surgery, Weight loss, Diabetes mellitus, Type 2

REFERENCES

1. SHossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N Engl J Med. 2007; 356:213–5.

2. SMust A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999; 282:1523–9.

3. SJia H, Lubetkin EI. The impact of obesity on health-related quality-of-life in the general adult US population. J Public Health (Oxf). 2005; 27:156–64.

4. SGoodrick GK, Poston WS 2nd, Foreyt JP. Methods for voluntary weight loss and control: update 1996. Nutrition. 1996; 12:672–6.

5. SSjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H. Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004; 351:2683–93.

6. SGersin KS, Rothstein RI, Rosenthal RJ, Stefanidis D, Deal SE, Kuwada TS, Laycock W, Adrales G, Vassiliou M, Szomstein S, Heller S, Joyce AM, Heiss F, Nepomnayshy D. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc. 2010; 71:976–82.

7. SBuchwald H, Oien DM. Metabolic/bariatric surgery Worldwide 2008. Obes Surg. 2009; 19:1605–11.

8. SBuchwald H, Oien DM. Metabolic/Bariatric surgery worldwide 2011. Obes Surg. 2013; 23:427–36.

9. SReoch J, Mottillo S, Shimony A, Filion KB, Christou NV, Joseph L, Poirier P, Eisenberg MJ. Safety of laparoscopic vs open bariatric surgery: a systematic review and meta-analysis. Arch Surg. 2011; 146:1314–22.

10. SSchirmer B. Laparoscopic bariatric surgery. Surg Endosc. 2006; 20(Suppl 2):S450–5.

11. SPonce J, Dixon JB. 2004 ABS Consensus Conference. Laparoscopic adjustable gastric banding. Surg Obes Relat Dis. 2005; 1:310–6.

12. SSchirmer B, Watts SH. Laparoscopic bariatric surgery. Surg Endosc. 2003; 17:1875–8.

13. SNguyen NT, Rivers R, Wolfe BM. Factors associated with operative outcomes in laparoscopic gastric bypass. J Am Coll Surg. 2003; 197:548–55.

14. SSmith MD, Patterson E, Wahed AS, Belle SH, Berk PD, Courcoulas AP, Dakin GF, Flum DR, Machado L, Mitchell JE, Pender J, Pomp A, Pories W, Ramanathan R, Schrope B, Staten M, Ude A, Wolfe BM. Thirty-day mortality after bariatric surgery: independently adjudicated causes of death in the longitudinal assessment of bariatric surgery. Obes Surg. 2011; 21:1687–92.

15. SLongitudinal Assessment of Bariatric Surgery (LABS) Consortium. Flum DR, Belle SH, King WC, Wahed AS, Berk P, Chapman W, Pories W, Courcoulas A, McCloskey C, Mitchell J, Patterson E, Pomp A, Staten MA, Yanovski SZ, Thirlby R, Wolfe B. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009; 361:445–54.

16. STack J, Blondeau K, Boecxstaens V, Rommel N. Review article: the pathophysiology, differential diagnosis and management of rumination syndrome. Aliment Pharmacol Ther. 2011; 33:782–8.

17. SZiegler O, Sirveaux MA, Brunaud L, Reibel N, Quilliot D. Medical follow up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treatment of nutritional deficiencies. Diabetes Metab. 2009; 35:544–57.

18. SRegan JP, Inabnet WB, Gagner M, Pomp A. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003; 13:861–4.

19. SAlmogy G, Crookes PF, Anthone GJ. Longitudinal gastrectomy as a treatment for the high-risk superobese patient. Obes Surg. 2004; 14:492–7.

20. SPeterli R, Wölnerhanssen B, Peters T, Devaux N, Kern B, Christoffel-Courtin C, Drewe J, von Flüe M, Beglinger C. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg. 2009; 250:234–41.

21. SKaramanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008; 247:401–7.

22. SGagner M, Deitel M, Kalberer TL, Erickson AL, Crosby RD. The Second International Consensus Summit for Sleeve Gastrectomy, March 19-21, 2009. Surg Obes Relat Dis. 2009; 5:476–85.

23. SAurora AR, Khaitan L, Saber AA. Sleeve gastrectomy and the risk of leak: a systematic analysis of 4,888 patients. Surg Endosc. 2012; 26:1509–15.

24. SBrethauer SA, Hammel JP, Schauer PR. Systematic review of sleeve gastrectomy as staging and primary bariatric procedure. Surg Obes Relat Dis. 2009; 5:469–75.

25. SLee CM, Cirangle PT, Jossart GH. Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc. 2007; 21:1810–6.

26. SBoza C, Gamboa C, Salinas J, Achurra P, Vega A, Pérez G. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy: a case-control study and 3 years of followup. Surg Obes Relat Dis. 2012; 8:243–9.

27. SMaggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH, Nguyen NT, Li Z, Mojica WA, Hilton L, Rhodes S, Morton SC, Shekelle PG. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005; 142:547–59.

28. SBuchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004; 292:1724–37.

29. SKehagias I, Karamanakos SN, Argentou M, Kalfarentzos F. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI < 50 kg/m². Obes Surg. 2011; 21:1650–6.

30. SBaltasar A, Serra C, Pérez N, Bou R, Bengochea M, Ferri L. Laparoscopic sleeve gastrectomy: a multipurpose bariatric operation. Obes Surg. 2005; 15:1124–8.

31. SBuchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009; 122:248–256. e5.

32. SMingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G, Rubino F. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012; 366:1577–85.

33. SRubino F, R'bibo SL, del Genio F, Mazumdar M, McGraw TE. Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol. 2010; 6:102–9.

34. SHayes MT, Hunt LA, Foo J, Tychinskaya Y, Stubbs RS. A model for predicting the resolution of type 2 diabetes in severely obese subjects following Roux-en Y gastric bypass surgery. Obes Surg. 2011; 21:910–6.

35. SSchauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012; 366:1567–76.

TOOLS

Similar articles